Tesamorelin

About this Compound

Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It has been studied in clinical and research settings for its ability to stimulate endogenous growth hormone (GH) release and increase IGF-1 activity. By acting on the GHRH receptor in the pituitary, Tesamorelin influences pathways involved in body composition, metabolism, and fat distribution. Research has primarily focused on its effects on visceral adipose tissue, metabolic markers, and growth hormone axis signaling.

Research Highlights

• Demonstrated reductions in visceral adipose tissue in clinical studies
• Stimulates endogenous growth hormone and IGF-1 production
• Studied for effects on abdominal fat distribution and body composition
• Investigated for potential improvements in metabolic markers
• Early research explores cognitive and neuroprotective implications